What Phylogene does

Phylogene is a French contract research organization (CRO) founded in 1999 and headquartered in Bernis, France, with 11-50 employees. The company provides specialized analytical services built on omics technologies (genomics, transcriptomics, proteomics, metabolomics) and associated bioinformatics. Its core technical stack centers on nanoLC-MS/MS, LC-MS/MS and high-resolution mass spectrometry (Orbitrap), complemented by proprietary bioinformatics pipelines CORAVALID (proteomics and transcriptomics validation) and HolXplore (metaproteomics with taxonomic, functional and KEGG pathway analyses), and a proprietary antibiotic resistance database called PROTABIORES (approximately 53,000 peptide and protein entries as of 2015). The company is COFRAC-accredited (n°1-2128) under ISO 17025 for allergen detection and quantification in food matrices and contributes to CEN and AFNOR standardization committees.

Phylogene serves four primary vertical markets: food and environment (allergen detection, GMO testing, species identification, microbiology), pharma and biopharma (drug discovery, biomarker identification), cosmetics (efficacy substantiation, mechanism of action, microbiome studies), and in vitro diagnostics (kit development). Secondary use cases include microbiome research (skin and gut host-microbe interactions) and biomarker discovery and validation. The company also develops and sells diagnostic kits, particularly for allergen detection. Strategic partnerships include co-development work with CEA on the DeepMicro metaproteomics project (2022), CTIBiotech for ex-vivo skin biopsy workflows, Dermatec for skin microbiome studies, and participation in EU-funded consortia (KINDReD FP7, NOSO-FIGHT Eurostars, ID-THON FUI).

The business model is professional services revenue from CRO engagements (quote-based, project-by-project) plus hardware/diagnostic kit sales. Go-to-market relies on direct B2B relationships, scientific conference presence (Cosmetotest, Microbiome Forum, IFSCC, BIO Digital, In-Cosmetics), and peer-reviewed publications. Distribution is regional (Europe, with France as the primary market), delivered through a single laboratory site. The company is privately held with no disclosed institutional investors and no public funding rounds beyond EU grant participation as a consortium partner.

Name

Phylogene

Legal name

Phylogene

Website

https://phylogene.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Phylogene is a French contract research organization founded in 1999 that delivers omics-based analytical services (proteomics, metabolomics, metaproteomics, genomics) and bioinformatics to pharmaceutical, cosmetics, food safety, and diagnostics clients across Europe from its Bernis laboratory.

Ownership category

akta.pro rank

Product category

Analytical Laboratory Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industries

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Contract research services
• Omics analytical services
• Proteomics laboratory
• Metabolomics analysis
• Bioinformatics pipelines

Headquarters

HQ city

Bernis

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. CRO Analytical Services: Contract research organization providing specialized analytical services in genomics, proteomics, metabolomics, and bioinformatics for identification, authentication, and biological effects discovery applications.
2. Kit Development: Development and sale of diagnostic kits for the diagnostics industry, particularly for allergen detection.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Phylogene is a Contract Research Organization (CRO) providing specialized analytical services in genomics, proteomics, metabolomics, metaproteomics, and bioinformatics for identification, authentication, and biological effects discovery. The company also develops diagnostic kits, particularly for allergen detection. Services are delivered from a COFRAC-accredited laboratory in Bernis, France, serving pharmaceutical, cosmetics, food industry, and diagnostic clients.

Product overview

Phylogene is a Contract Research Organization (CRO) founded in 1999, offering specialized analytical services in omics and associated bioinformatics for discovery applications in pharma, cosmetics, and food allergen detection. The company operates as a unified services platform organized by technology areas: Proteomics Services (shotgun proteomics, TMT labeling, DIA, PRM quantification, phosphoproteomics), Metabolomics Services (targeted and untargeted approaches), Metaproteomics Services for microbiome analysis, Genomics Services (PCR, sequencing), and Bioinformatics Modules (CORAVALID for proteome/transcriptome validation, HolXplore for metaproteome analysis). These core analytical services are complemented by specialized offerings including Multi-Omics integration, Allergen Detection, Host Cell Proteins analysis, and Lipidomics. The company employs mass spectrometry (nanoLC-MS/MS on Orbitrap instruments) as the primary analytical platform and is COFRAC accredited for allergen testing.

Differentiator

Problem solved

Functional benefit

Brands

• MS-Phylogene: Mass spectrometry division of Phylogene mentioned in company communications.

Products and services

• Proteomics Services

Quantifiable outcome

• Detection sensitivity of 0.25ppm threshold for allergen labeling compliance in wine (OIV-COMEX 502-2012)
• +2 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• CEA (Commissariat à l'énergie atomique et aux énergies alternatives)coreStrategic or Co-development Partner · 1 January 2022DeepMicro project - PHYLOGENE and CEA associate for microbiome study, developing metaproteomics for understanding microbiomes. This is a co-development partnership focused on advancing metaproteomics technology for microbiome analysis.
• CTIBiotechcoreStrategic or Co-development Partner · 1 January 2022Collaboration for non-targeted proteomics on ex-vivo skin kits. CTIBiotech provides skin biopsy kits, customers apply products and send biopsies to Phylogene for proteomics analysis.
• DermateccoreStrategic or Co-development PartnerCollaboration on skin microbiome studies. Dermatec provides clinical trial design and volunteer cohorts; Phylogene provides genomics/proteomics testing and bioinformatics analysis.
• HistalimminorStrategic or Co-development PartnerJoint TissueScreen platform from biobank to Antibody Drug Conjugate development
• DSMcoreStrategic or Co-development PartnerCollaboration on skin research including poster presentations at SID 2016 on UV effects on stratum corneum using high-resolution quantitative LC-MS/MS proteomics
• KINDReD ConsortiumcoreStrategic or Co-development PartnerFP7-Health-2013 Innovation project (36 months, 14 partners) developing drug candidates against kinetoplastids. Phylogene is WP leader for drug target determination.
• NOSO-FIGHTminorStrategic or Co-development PartnerEurostars funded project on healthcare-associated infections
• ID-THONminorStrategic or Co-development PartnerFUI funded project on tuna species identification

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Others

• Sciex: Sciex (Danaher) is a major mass spectrometry instrumentation and software provider. Functions as enabling technology provider and adjacent ecosystem participant rather than a direct services competitor to Phylogene.

Direct peers

• MS Bioworks: US-based mass spectrometry CRO specializing in protein identification, characterization, and quantitative proteomics for pharma and biotech. Closely comparable to Phylogene's high-resolution LC-MS/MS proteomics platform.
• Metabolon: Metabolon is a US-based metabolomics CRO offering targeted and untargeted metabolic profiling for pharma, nutrition, and consumer health applications. Directly comparable to Phylogene's metabolomics services for biomarker discovery and cosmetics/pharma claim substantiation.
• Biocrates Life Sciences: Biocrates provides standardized metabolomics kits and CRO services for clinical research, pharma, and nutrition. Comparable to Phylogene's targeted metabolomics quantification and biomarker work in pharma/biopharma and nutrition verticals.
• Active Motif: Active Motif offers proteomics and epigenetics services and kits to pharma and academic customers. Comparable to Phylogene's biomarker and proteomics services in pharma and diagnostics verticals.
• Biognosys: Swiss proteomics CRO offering LC-MS/MS-based protein quantification services (DIA, PRM, TMT) for pharma biomarker discovery. Direct competitor to Phylogene's proteomics and phosphoproteomics service lines.
• CTIBiotech: CTIBiotech is a French CRO providing ex-vivo skin tissue kits and 3D tissue models for cosmetics and pharma testing. Active co-development partner of Phylogene for non-targeted proteomics on ex-vivo skin biopsies; serves the same cosmetics and dermocosmetic customers.

Broad incumbents

• Charles River Laboratories: Charles River is a global CRO offering discovery, safety assessment, and manufacturing services to biopharma. Comparable to Phylogene's preclinical/discovery and biomarker work but operates at vastly larger scale with broader service portfolio.
• Eurofins Scientific: Eurofins is a global life-sciences testing giant with broad food, pharma, cosmetics, and environmental testing offerings. Overlaps with Phylogene's allergen testing, GMO detection, and food safety services but at vastly larger scale and scope.

Regional players

• Genomic Vision: Genomic Vision is a French molecular genomics company providing DNA detection and visualization tools. Regionally comparable French peer in genomics services, with overlap in molecular biology detection capabilities though different application focus.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Phylogene_One
• LinkedInlinkedin.com/company/phylogene

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phylogene